SEC Form 4 · accession 0001235802-18-000159
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Cooke
Officer — President, International
Period of report
Nov 2, 2018
Accepted (ET)
Nov 6, 2018 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2 | Nov 2, 2018 | M | 4,793 | $20.62 | A | 33,663 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Nov 2, 2018 | M | 6,277 | $21.24 | A | 39,940 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF3,F2 | Nov 2, 2018 | S | 13,478 | $28.0259 | D | 26,462 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $20.62 | Nov 2, 2018 | M | 4,793 | D | — | Oct 13, 2025 | Ordinary Shares | 4,793 | 30,367 | D |
| Stock Option (right to buy)F5 | $21.24 | Nov 2, 2018 | M | 6,277 | D | — | Jul 19, 2026 | Ordinary Shares | 6,277 | 14,931 | D |
Explanation of responses
- F1These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2Includes 10,666 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 8,863 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.12, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4This option vests with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- F5This option vests with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.